Cite

HARVARD Citation

    Vingerhoets, J. et al. (2013). Pre-Existing Mutations in the Rilpivirine Phase Iii Trials Echo and Thrive: Prevalence and Impact on Virological Response. Antiviral therapy. 18 (2), pp. 253-256. [Online]. 
  
Back to record